QQ客服 官方微博 反馈留言

	Pharmacokinetics and Preliminary Pharmacodynamics of Single- and Multiple-dose Lyophilized Recombinant Glucagon-like Peptide-1 Receptor Agonist (rE-4) in Chinese Patients with Type 2 Diabetes Mellitus
	Wang Yitong[1]; Xu Bingfeng[2]; Zhu Lixia[3]; Lou Kun[4]; Chen Yingli[5]; Zhao Xia[6]; Wang Qian[7]; Xu Ling[8]; Guo Xiaohui[9]; Ji Linong[10]
刊名	Clinical drug investigation
	2017
卷号	37页码:1107-1115
ISSN号	1179-1918
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2224303
专题	上海大学
作者单位	1.[1]Department of Pharmacy, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China. 2.[2]Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical College, Xuzhou, 221004, China. 3.[3]Clinical Medicine Department, CSPC Zhongqi Pharmaceutical Technology Co., Ltd, Hebei, 050035, China. 4.[4]Clinical Medicine Department, CSPC Zhongqi Pharmaceutical Technology Co., Ltd, Hebei, 050035, China. 5.[5]Department of Endocrinology, Peking University People's Hospital, Beijing, 100044, China. 6.[6]Department of Pharmacy, Peking University First Hospital, No. 8 XiShiKu Street, Xi Cheng District, Beijing, 100034, China. 7.[7]Department of Pharmacy, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China. 8.[8]Shanghai University of Chinese Medicine, Shanghai, 201203, China. 9.[9]Department of Endocrinology, Peking University First Hospital, Beijing, 100034, China. 10.[10]Department of Endocrinology, Peking University People's Hospital, Beijing, 100044, China.
推荐引用方式 GB/T 7714	Wang Yitong[1],Xu Bingfeng[2],Zhu Lixia[3],et al. Pharmacokinetics and Preliminary Pharmacodynamics of Single- and Multiple-dose Lyophilized Recombinant Glucagon-like Peptide-1 Receptor Agonist (rE-4) in Chinese Patients with Type 2 Diabetes Mellitus[J]. Clinical drug investigation,2017,37:1107-1115.
APA	Wang Yitong[1].,Xu Bingfeng[2].,Zhu Lixia[3].,Lou Kun[4].,Chen Yingli[5].,...&Fang Yi[12].(2017).Pharmacokinetics and Preliminary Pharmacodynamics of Single- and Multiple-dose Lyophilized Recombinant Glucagon-like Peptide-1 Receptor Agonist (rE-4) in Chinese Patients with Type 2 Diabetes Mellitus.Clinical drug investigation,37,1107-1115.
MLA	Wang Yitong[1],et al."Pharmacokinetics and Preliminary Pharmacodynamics of Single- and Multiple-dose Lyophilized Recombinant Glucagon-like Peptide-1 Receptor Agonist (rE-4) in Chinese Patients with Type 2 Diabetes Mellitus".Clinical drug investigation 37(2017):1107-1115.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。